Point-of-Care Glucose Testing Market Report 2026

Point-of-Care Glucose Testing Market Overview

• Point-of-Care Glucose Testing market size has reached to $5.14 billion in 2025 • Expected to grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: The Surge In Diabetes Propels Point-Of-Care Glucose Testing Market Growth • Market Trend: Adoption of Continuous Glucose Monitoring Systems for Real-Time Diabetes Management • North America was the largest region in 2025.

What Is Covered Under Point-of-Care Glucose Testing Market?

Point-of-care glucose testing is referred to as a quality-assured pathology service delivered close to the patient rather than in the usual setting of a clinical laboratory. It is used for glucose testing by clinicians or individuals using small handheld units or glucose analyzers that use testing strips to analyze whole blood, thereby reducing the time from specimen collection to result in verification and translating to faster therapeutic intervention, reduced preanalytical errors, and improved patient care. The main types of products in point-of-care glucose testing are lancet and lancing devices, strips, and meters. Lancets are small, sharp instruments used to puncture the skin to draw a small drop of blood for testing purposes, whereas lancing devices are intended to firmly grasp the lancet and are controlled by merely pushing a button and these are used in point-of-care glucose testing for simple blood withdrawal and evaluating blood glucose levels using a blood glucose monitor and blood glucose test strips. The various testing sites are fingertips and alternate site testing that are applied in type-1 diabetes and type-2 diabetes. These are used by various end-user such as professional diagnostic centers, hospitals and clinics, home care settings, and others.

What Is The Point-of-Care Glucose Testing Market Growth Forecast?

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growing adoption of connected glucose monitoring systems, rising integration with mobile health applications, increasing demand for non-invasive monitoring, expansion of remote patient monitoring programs, growing focus on personalized diabetes management. Major trends in the forecast period include increasing adoption of bluetooth-enabled glucose meters, rising use of continuous glucose monitoring devices, growing preference for home-based glucose testing, expansion of digital diabetes management platforms, enhanced focus on patient self-monitoring.

Global Point-of-Care Glucose Testing Market Segmentation

1) By Product: Lancet And Lancing Devices, Strips, Meters 2) By Testing Site: Fingertips, Alternate Site Testing 3) By Applications: Type-1 Diabetes, Type-2 Diabetes 4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users Subsegments: 1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices 2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone) 3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

What Is The Driver Of The Point-of-Care Glucose Testing Market?

The growing prevalence of diabetes is expected to propel the growth of the point-of-care glucose testing market going forward. Diabetes is a chronic metabolic disorder that elevates blood glucose levels, leading over time to severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is a frequently used technology for determining glucose levels in hospitalized patients, facilitating prompt treatment decisions in response to glycemia changes, and enhancing therapeutic output and diabetes management. For instance, in June 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, marking an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the growing prevalence of diabetes is driving the growth of the point-of-care glucose testing industry.

Key Players In The Global Point-of-Care Glucose Testing Market

Major companies operating in the point-of-care glucose testing market are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, Nipro Corporation, Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Medtronic plc

Global Point-of-Care Glucose Testing Market Trends and Insights

Major companies are operating in the point-of-care glucose testing market, focusing on developing technological advancements such as wearable continuous glucose monitoring (CGM) systems with predictive analytics to enhance real-time glucose tracking, improve glycemic control, and reduce the manual testing burden. A CGM system uses a small sensor inserted under the skin that continuously measures interstitial glucose levels and sends the data to a mobile app allowing proactive management through real-time alerts and trend predictions. For instance, in July 2024, Roche, a Switzerland-based diagnostics company, launched the Accu-Chek SmartGuide CGM system designed for patients with diabetes. The product provides real-time glucose readings every five minutes, integrates AI-powered trend prediction for up to two hours ahead, offers overnight alerts for hypo- or hyperglycemia, and connects seamlessly to a mobile app for data tracking and remote healthcare monitoring, enhancing safety and convenience compared to traditional finger-prick glucose meters.

What Are Latest Mergers And Acquisitions In The Point-of-Care Glucose Testing Market?

In August 2024, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, acquired Point of Care technology from LumiraDx Ltd. for an undisclosed amount. The acquisition allows Roche to enhance its diagnostics portfolio by integrating a versatile platform that consolidates multiple tests on a single instrument, supporting the expansion of decentralized healthcare solutions. LumiraDx Ltd. is a UK-based point-of-care diagnostics company offering glucose testing solutions.

Regional Outlook

North America was the largest region in the point-of-care glucose testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point-of-Care Glucose Testing Market?

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point-of-Care Glucose Testing Market Report 2026?

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.